RP Disease Team Receives $17.1 Million from CIRM

Henry Klassen, MD, PhD, associate professor of ophthalmology at UC Irvine’s Sue & Bill Gross Stem Cell Research Center, and collaborators at UC Santa Barbara and Cedars-Sinai Medical Center, have received $ 17.1 million from the California Institute for Regenerative Medicine (CIRM) to create stem cells to treat retinitis pigmentosa (RP).

The research will use a type of stem cell called retinal progenitor cells to rescue and reactivate damaged and dying photoreceptors (rods and cones). The grant will support the group’s efforts to grow these cells under pharmaceutical conditions, test them for safety and ensure they are therapeutically potent.

Ultimately, the disease team will seek FDA approval to use these cells in clinical trials to test whether this treatment is safe in humans and effective against RP.






Leave a comment